期刊文献+

瘢痕疙瘩成纤维细胞端粒酶活性及相关基因的表达 被引量:2

Telomerase activation and related gene expression of keloid fibroblasts
下载PDF
导出
摘要 背景:研究发现人端粒酶催化亚单位在瘢痕疙瘩组织中有高表达。目的:拟进一步验证瘢痕疙瘩成纤维细胞中端粒酶活性及端粒酶催化亚单位、bcl-2mRNA在瘢痕疙瘩成纤维细胞中的表达及其在瘢痕疙瘩发生、发展中的意义。设计、时间及地点:单一样本观察,于2005-03/2006-01在解放军第二军医大学长海医院整形外科完成。对象:实验标本取自8例瘢痕疙瘩标本和8例正常皮肤标本。提供者对实验知情同意。方法:取瘢痕疙瘩边缘突起发红的部分,按组织块法培养原代成纤维细胞,取第三四代的细胞用于实验。主要观察指标:用PCR-ELISA方法测定瘢痕疙瘩和正常皮肤成纤维细胞端粒酶活性;用反转录-聚合酶链反应的方法检测培养的瘢痕疙瘩和正常皮肤成纤维细胞人端粒酶催化亚单位、bcl-2mRNA的表达情况。结果:①PCR-ELISA结果表明:瘢痕疙瘩成纤维细胞端粒酶活性明显高于正常皮肤成纤维细胞,其差异有非常显著性意义(P<0.01)。②反转录-聚合酶链反应结果显示:端粒酶催化亚单位和bcl-2mRNA在瘢痕疙瘩成纤维细胞中有较强的表达,在正常皮肤成纤维细胞中表达较弱,前者显著高于后者(P<0.01)。结论:瘢痕疙瘩成纤维细胞中端粒酶活性明显增高。推测人端粒酶催化亚单位mRNA在瘢痕疙瘩成纤维细胞中的高表达与端粒酶活性密切相关。 BACKGROUND: Previous study reveals that, telomerase catalytic subunit is highly expressed in keloid tissues. OBJECTIVE: To further verify the telomerase activation and the expression of human telomerase reverse transcriptase (hTERT) and bcl-2 mRNA in keloid fibroblast, and approach its role in the formation and development of keloid. DESIGN, TIME AND SETTING: A single sample observation was carded out in the Department of Plastic Surgery, Changhai Hospital, the Second Military Medical University of Chinese PLA (Shanghai, China) from March 2005 to January 2006. PARTICIPANTS: Eight keloid and normal skin were selected. All donators signed the informed consents. METHODS: Keloid tissues with prominences and redness were harvested. Subsequent to primary cultures, dermal fibroblasts at passages 3 to 4 were used in this study. MAIN OUTCOME MEASURES: The samples from 8 keloid fibroblast cell lines and 8 normal skin fibroblast cell lines were examined by using polymerase chain reaction-enzyme-linked immunoadsorbent assay (PCR-ELISA) for telomerase activation. The expression of hTERT and bcl-2 mRNA in the fibroblasts derived from keloid and normal skin tissue was detected by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). RESULTS: PCR-ELISA result showed the telomerase activation of keloid fibroblasts was extremely significantly higher than that of normal skin fibroblasts (P 〈 0.01). RT-PCR analysis showed the expression of hTERT and bcl-2 mRNA was strong in keloid, whereas was weak in normal skin. The keloid fibroblasts revealed a significant higher expression compared to normal skin (P 〈 0.01 ). CONCLUSION: The telomerase activation of keloid fibroblasts obviously hoists. High expression of hTERT mRNA in the fibroblasts of keloid may be related to the telomerase activation.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第33期6488-6491,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献4

二级参考文献30

  • 1[1]Wyllie AH. The genetic regulation of apoptosis[J]. Curr Opin Genet Dev, 1995; 5(1):97-104.
  • 2[2]Pezzella F, Turley H, Kuzu I . bcl-2 protein in non-small-cell lung carcinoma[J]. N Engl J Med, 1993; 329(10): 690-694.
  • 3[3]Anton RC, Brown RW, Younes M, Gondo MM, Stephenson MA, Cagle PT. Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer analysis of 427 cases[J]. Hum Pathol, 1997; 28(9):1079-1082.
  • 4[4]Kim YC, Park KO, Kern JA, Park CS, Lim SC, Jang AS, Yang JB. The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients[J]. Lung Cancer, 1998; 22(3):181-190.
  • 5[5]McLaren R, Kuzu I, Dunnill M. The relationship of p53 immunostaining to survival in carcinomaof the lung[J]. Br J Cancer, 1992; 66(4): 735-738.
  • 6[6]Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Angeletti CA, Basolo F, Bevilacqua G. Bcl-2 protein: A prognostic factor inversely correlated to p53 in non-small-cell lung cancer[J]. Br J Cancer, 1995; 71(5):1003-1007.
  • 7[7]Ohmura Y, Aoe M, Andou A, Shimizu N. Telomerase activity and bcl-2 expression in non-small cell lung cancer[J]. Clin Cancer Res, 2000; 6(8):2980-2987.
  • 8[8]Wang L, Soria JC, Kemp BL. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer[J]. Clin Cancer Res, 2002; 8(9):2883-2889.
  • 9[9]Mandal M, Kumar R. Bcl-2 modulates telomerase activity[J]. J Biol Chem, 1997; 272(22): 14183-14187.
  • 10[10]Albanell J, Lonardo F, Rusch V. High telomerase activity in primary lung cancers: Association with increased cell proliferation rates and advanced pathologicstage[J]. J Natl Cancer Inst, 1997; 89(21):1609-1615.

共引文献44

同被引文献36

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部